CAJ | 학술논문

目的：探讨舒立松联合噻托溴铵治疗慢性阻塞性肺疾病的疗效。方法：选取我院诊断为慢性阻塞性肺疾病的患者87例，随机分为两组，观察组(给予舒立松联合噻托溴铵治疗)42例和对照组(给予噻托溴铵治疗)45例。所有患者均规律治疗12周，12周后比较两组的治疗效果。结果：规律治疗12周后，观察组患者的治疗有效率为95.24%，对照组为77.78%，观察组有效率明显高于对照组，比较差异有统计学意义( P<0.05)。两组患者均无明显不良反应发生。结论：舒立松联合噻托溴铵治疗慢性阻塞性肺疾病临床疗效明显，优于单纯噻托溴铵治疗，值得临床推广和应用。
목적：탐토서립송연합새탁추안치료만성조새성폐질병적료효。방법：선취아원진단위만성조새성폐질병적환자87례，수궤분위량조，관찰조(급여서립송연합새탁추안치료)42례화대조조(급여새탁추안치료)45례。소유환자균규률치료12주，12주후비교량조적치료효과。결과：규률치료12주후，관찰조환자적치료유효솔위95.24%，대조조위77.78%，관찰조유효솔명현고우대조조，비교차이유통계학의의( P<0.05)。량조환자균무명현불량반응발생。결론：서립송연합새탁추안치료만성조새성폐질병림상료효명현，우우단순새탁추안치료，치득림상추엄화응용。
Objective: To investigate Shuli Song combined therapy with tiotropium in chronic obstructive pulmonary disease. Methods: The hospital diagnosed patients with chronic obstructive pulmonary disease, 87 cases were randomly divided into two groups, the observation group (given Shuli Song joint tiotropium therapy) 42 cases and the control group (given tiotropium therapy) 45 cases. Al patients were treated for 12 weeks law, comparing the two groups after 12 weeks of treatment. Results: After 12 weeks of treatment law, effective treatment of patients in the observation group was 95.24%, the control group was 77.78% in the observation group was significantly higher efficiency, the difference was statisticaly significant (P <0.05). Two patients had no significant adverse reactions occur. Conclusion: Shuli Song tiotropium combined clinical efficacy of treatment of chronic obstructive pulmonary disease was significantly better than treatment with tiotropium alone is worthy of promotion and application.